BUSINESS

Takeda Chips in for Govt’s Workplace COVID-19 Immunization Drive

June 9, 2021

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Takeda Pharmaceutical said on June 8 that it will implement its workplace COVID-19 immunization program as early as July, planning to start vaccinations as soon as the necessary arrangements are completed. The company will set up immunization sites at its…

To read the full story

Bristol Myers Kicks Off COVID-19 Inoculation Program, Eliminates Cost Burden on Employees
July 8, 2021
Bristol Myers, Other Pharma Players Moving to Join Workplace Vaccination Campaign
June 7, 2021

BUSINESS

Japan IP High Court Upholds Invalidation of Key Trazenta Dosage Patent
February 19, 2026
ONODERA GT Pharma Targets 2026 Filings for Two Gene Therapies
February 19, 2026
Sumitomo Pharma Sees iPSC Therapy as Potential US$1 Billion Global Product
February 18, 2026
AstraZeneca Launches Japan Registry Study of Imfinzi in Limited-Stage SCLC
February 18, 2026
Asahi Kasei Gets Global Rights to Alchemedicine’s Lead Compounds
February 18, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Hisamitsu’s MBO: Is Shareholder Accountability Trust-Building or a Shackle?

By Hayate Horiguchi

Following Hisamitsu Pharmaceutical’s decision to go private through a roughly 400 billion yen management buyout (MBO), industry observers are weighing…

COLUMN

AI in Healthcare Hiring: Leveling the Playing Field & Unlocking Human Potential

By Philip Carrigan

The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…